Tower Research Capital LLC (TRC) - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 130 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$53,578
-18.4%
1,165
+2.0%
0.00%0.0%
Q2 2023$65,631
+87408.0%
1,142
-42.8%
0.00%0.0%
Q1 2023$75
+316.7%
1,998
+206.9%
0.00%
+100.0%
Q4 2022$18
-100.0%
651
-87.3%
0.00%
-50.0%
Q3 2022$144,000
+97.3%
5,143
+145.0%
0.00%0.0%
Q2 2022$73,000
-80.3%
2,099
-79.6%
0.00%
-50.0%
Q1 2022$370,000
+1380.0%
10,283
+846.0%
0.00%
Q4 2021$25,000
-70.6%
1,087
-75.7%
0.00%
-100.0%
Q3 2021$85,000
+84.8%
4,467
+97.5%
0.00%
+100.0%
Q2 2021$46,000
+9.5%
2,262
-2.1%
0.00%0.0%
Q1 2021$42,000
+100.0%
2,310
+122.8%
0.00%0.0%
Q4 2020$21,000
-92.1%
1,037
-92.7%
0.00%
-66.7%
Q3 2020$266,000
+202.3%
14,162
+260.4%
0.00%
-25.0%
Q2 2020$88,000
+780.0%
3,929
+678.0%
0.00%
+300.0%
Q1 2019$10,000
-75.0%
505
-80.9%
0.00%
-50.0%
Q2 2018$40,000
-20.0%
2,642
-0.6%
0.00%
-50.0%
Q1 2018$50,000
-63.2%
2,658
-65.1%
0.00%
-63.6%
Q3 2017$136,000
+267.6%
7,623
+198.0%
0.01%
+175.0%
Q1 2017$37,000
+37.0%
2,558
+75.7%
0.00%
+33.3%
Q4 2016$27,000
+50.0%
1,456
+29.7%
0.00%
+50.0%
Q2 2016$18,000
+80.0%
1,123
+40.4%
0.00%
+100.0%
Q1 2016$10,000
-80.8%
800
-73.0%
0.00%
-80.0%
Q2 2015$52,000
+420.0%
2,960
+239.4%
0.01%
+400.0%
Q4 2014$10,000
-81.8%
872
-81.7%
0.00%
-83.3%
Q3 2014$55,0004,7600.01%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q4 2020
NameSharesValueWeighting ↓
LAM GROUP, INC. 130,250$3,649,6053.75%
SHAKER INVESTMENTS LLC/OH 81,287$2,277,6621.41%
Mesirow Institutional Investment Management, Inc. 374,414$10,491,0801.38%
OBERWEIS ASSET MANAGEMENT INC/ 134,000$3,754,6800.80%
Portolan Capital Management 270,791$7,587,5640.75%
Hillsdale Investment Management Inc. 172,238$4,826,1090.41%
Capital Impact Advisors, LLC 14,669$411,0250.40%
Watershed Asset Management, L.L.C. 9,555$267,7310.34%
Quantedge Capital Pte Ltd 35,153$984,9870.33%
FEDERATED HERMES, INC. 3,284,217$92,023,7600.25%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders